2,6-Dihydroxybenzoic acid

2,6-Dihydroxybenzoic acid (CAS No.: 303-07-1) is an aromatic phenolic acid and a secondary metabolite derived from salicylic acid, formed through enzymatic hydrolysis processes associated with hepatic phase I metabolism, and is also detected in certain natural matrices such as olive oil wastewater. As a member of the hydroxybenzoic acid family, this compound is widely utilized in biochemical and pharmacological research as a model substrate for investigating liver enzyme activity, particularly in studies of oxidative and hydrolytic metabolic pathways and their underlying enzymatic mechanisms. Its structural features, characterized by the presence of phenolic hydroxyl and carboxyl functionalities, support its application in probing conjugation reactions, redox transformations, and metabolite profiling, thereby contributing to the elucidation of biotransformation routes and metabolic networks. Although specific molecular targets are not comprehensively defined, it is commonly employed in studies examining enzyme-mediated metabolism, including interactions with oxidoreductases and hydrolases relevant to xenobiotic processing. In vitro investigations typically explore its activity within low micromolar to millimolar concentration ranges depending on assay design, while in cell-based and preclinical experimental systems it serves as a reference or intermediate for biomarker identification, pharmacokinetic characterization, and comparative metabolism studies, with dosing and exposure conditions tailored to the objectives of each experimental framework.